| Entry |
|
|---|
| Name |
Iratumumab (USAN) |
|---|
| Efficacy |
Antineoplastic, Anti-CD30 antibody |
|---|
| Type |
Monoclonal antibody |
|---|
| Comment |
Treatment of relapsed or refractory CD30 positive lymphoma including Hodgkin's disease
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04060 | Cytokine-cytokine receptor interaction |
|
|---|
| Brite |
Target-based classification of drugs [BR:br08310]
Cytokines and receptors
Cytokine receptors
Tumor necrosis factor receptors
TNFRSF8 (CD30)
D04612 Iratumumab (USAN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
